Thirty employees of pharmaceutical giant Sigma-Herron have been made redundant in Brisbane, with workers given no warning they'd lost their jobs, a union says. National Union of Workers (NUW) organiser Duncan Pegg said these were the first layoffs at the Tennyson factory, in southern Brisbane, since the company announce… Read all
Sigma-Herron retrenches 30 Brisbane jobs
|
CathRx refines its strategy, signs “heads of agreement” with Pioneer Medical
CathRx re-focuses resources on modular device manufacturing platform following the appointment of Jeff Goodman as Chief Executive Officer, cardiac catheter manufacturer CathRx Ltd (ASX: CXD) announced today that it will be refocusing the resources of the Company effective immediately. CathRx will focus its activities o… Read all |
CSL Ltd. gets U.S. approval to sell a new drug for primary immunodeficiency
|
Ramsay posts solid H1 profit growth
Ramsay Health Care has posted a 2009-10 interim net profit of $A78.62m, which is 46.2 per cent higher than previously. The private hospital group's revenue of $A1.685bn was 4.6 per cent higher, and it expects its full-year profit to increase by 18-20 per cent. This equates to growth in earnings per share of 10-12 per cent… Read all
|
Avexa HIV Integrase Option Period with Tibotec Expires
Tibotec will not continue its option on Avexa’s early stage HIV integrase program and the agreement will be allowed to expire effective March 2nd. Tibotec has chosen to let the option period expire due to potential future conflicts with its own internal programs. During the exclusivity period Tibotec profiled a number of … Read all
|
QRxPharma Limited and China Aoxing Pharmaceutical CompanyAnnounce Strategic Alliance for Development of MoxDuo®IV
QRxPharma Limited (ASX:QRX), and China Aoxing Pharmaceutical Company (OTCBB：CAXG) (“China Aoxing”) announced today a strategic alliance to collaborate in the development of MoxDuo®IV, an intravenous formulation of QRxPharma’s patented morphine and oxycodone Dual-Opioid™ technology for the acute treatment o… Read all |
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use